Samsung Biologics market cap
As of November 2026, Samsung Biologics (207940) has a market capitalization of $50.11 B, which makes it #399 among the world’s largest public companies. Over the past year its value changed by −7.42%.
Market cap$50.11 B
World rank#399
1 year−7.42%
Share price$1,014.83
Market cap over time
By year
| Year | Value | Change |
|---|---|---|
| 2026 | $50.11 B | −13.9% |
| 2025 | $58.21 B | +18.5% |
| 2024 | $49.10 B | +10.1% |
| 2023 | $44.61 B | −9.76% |
| 2022 | $49.44 B | −13.3% |
| 2021 | $57.02 B | −0.19% |
| 2020 | $57.12 B | +103% |
| 2019 | $28.13 B | +8.15% |
| 2018 | $26.01 B | −0.48% |
| 2017 | $26.14 B | — |
Market cap history is an estimate: monthly closing price × today’s share count, in US dollars at today’s exchange rate. Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.